MV Capital Management’s Insmed INSM Stock Holding History

MV Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.45K	Buy	23 +15	+188%	+$1.82K	﹤0.01%	754
2026 Q1	$1.31K	Sell	8 -5	-38%	-$769	﹤0.01%	818
2025 Q4	$2.26K	Buy	13 +3	+30%	+$547	﹤0.01%	711
2025 Q3	$1.44K	Buy	10 +6	+150%	+$735	﹤0.01%	745
2025 Q2	$403	Buy	+4	New	+$306	﹤0.01%	878

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

MV Capital Management's INSM Position: Q2 2026 in Review

MV Capital Management increased its Insmed (INSM) stake by 188% in Q2 2026, buying an estimated $1.82K and bringing the position to 23 shares worth $2.45K. The position accounts for ﹤0.01% of the portfolio, ranked #754.

MV Capital Management first reported a position in INSM in Q2 2025 and has held it in 5 quarters since. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

MV Capital Management held 23 shares of Insmed worth $2.45K as of Q2 2026.
MV Capital Management bought 15 Insmed shares in Q2 2026, an estimated $1.82K.
Insmed made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #754 holding.
MV Capital Management first reported a position in Insmed in Q2 2025 and has held it in 5 quarters since.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.